NCT01699464View on ClinicalTrials.gov

A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months

PHASE2CompletedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Ocular HypertensionOpen-angle Glaucoma
Interventions
DRUG

AR-12286 Ophthalmic Solution 0.7%

Ophthalmic Solution

DRUG

AR-12286 Ophthalmic Solution 0.5%

Ophthalmic Solution

DRUG

Timolol maleate ophthalmic solution 0.5%

Ophthalmic Solution

Sponsors
All Listed Sponsors
lead

Aerie Pharmaceuticals

INDUSTRY

NCT01699464 - A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months | Biotech Hunter | Biotech Hunter